|

Epirubicin (E) Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 2

Top Sponsors

  • Second Affiliated Hospital, School of Medicine, Zhejiang University1
  • Eye & ENT Hospital of Fudan University1

Indications

  • Cancer2
  • Epirubicin1
  • Sinonasal Carcinoma1
  • ER+/HER2- Breast Cancer1
  • Adenoid Cystic Carcinoma1

Other2 trials

Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study
Phase 2
Study of High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab Plus Chemotherapy Versus Chemotherapy as Neoadjuvant Therapy for Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (NeoHunter)
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.